Richard Holliday1, Ralf Kist1, Linda Bauld2. 1. Centre for Oral Health Research, Newcastle University, Newcastle upon Tyne, UK. 2. Institute of Social Marketing, University of Stirling, Sterling, Scotland.
Abstract
MATERIALS AND METHODS: In vitro experiments were performed on normal epithelial cells as well as head and neck squamous cell carcinoma (HNSCC) cell lines. The widely available cell line HaCat, a spontaneously transformed immortal keratinocyte and the HNSCC cell lines HN30 and UMSCC10B were used. Cells were exposed to nicotine-containing and nicotine-free vapour extract from two popular e-cigarette brands for periods ranging from 48 hours to eight weeks. Cytotoxicity was assessed using Annexin V flow cytometric analysis, trypan blue exclusion and clonogenic assays. Genotoxicity in the form of DNA strand breaks was quantified using the neutral comet assay and γ-H2AX immunostaining. RESULTS: E-cigarette-exposed cells showed significantly reduced cell viability and clonogenic survival, along with increased rates of apoptosis and necrosis, regardless of e-cigarette vapour nicotine content. They also exhibited significantly increased comet tail length and accumulation of γ-H2AX foci, demonstrating increased DNA strand breaks. CONCLUSIONS: In conclusion, our study strongly suggests that electronic cigarettes are not as safe as their marketing makes them appear to the public. Our in vitro experiments employing two brands of e-cigs show that at biologically relevant doses, vapourised e-cig liquids induce increased DNA strand breaks and cell death, and decreased clono- genic survival in both normal epithelial and HNSCC cell lines independently of nicotine content. Further research is needed to definitively determine the long-term effects of e-cig usage, as well as whether the DNA damage shown in our study as a result of e-cig exposure will lead to mutations that ultimately result in cancer.
MATERIALS AND METHODS: In vitro experiments were performed on normal epithelial cells as well as head and neck squamous cell carcinoma (HNSCC) cell lines. The widely available cell line HaCat, a spontaneously transformed immortal keratinocyte and the HNSCC cell lines HN30 and UMSCC10B were used. Cells were exposed to nicotine-containing and nicotine-free vapour extract from two popular e-cigarette brands for periods ranging from 48 hours to eight weeks. Cytotoxicity was assessed using Annexin V flow cytometric analysis, trypan blue exclusion and clonogenic assays. Genotoxicity in the form of DNA strand breaks was quantified using the neutral comet assay and γ-H2AX immunostaining. RESULTS: E-cigarette-exposed cells showed significantly reduced cell viability and clonogenic survival, along with increased rates of apoptosis and necrosis, regardless of e-cigarette vapour nicotine content. They also exhibited significantly increased comet tail length and accumulation of γ-H2AX foci, demonstrating increased DNA strand breaks. CONCLUSIONS: In conclusion, our study strongly suggests that electronic cigarettes are not as safe as their marketing makes them appear to the public. Our in vitro experiments employing two brands of e-cigs show that at biologically relevant doses, vapourised e-cig liquids induce increased DNA strand breaks and cell death, and decreased clono- genic survival in both normal epithelial and HNSCC cell lines independently of nicotine content. Further research is needed to definitively determine the long-term effects of e-cig usage, as well as whether the DNA damage shown in our study as a result of e-cig exposure will lead to mutations that ultimately result in cancer.
Authors: D L Ashley; D Burns; M Djordjevic; E Dybing; N Gray; S K Hammond; J Henningfield; M Jarvis; K S Reddy; C Robertson; G Zaatari Journal: World Health Organ Tech Rep Ser Date: 2008
Authors: Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Vicky Yu; Mehran Rahimy; Avinaash Korrapati; Yinan Xuan; Angela E Zou; Aswini R Krishnan; Tzuhan Tsui; Joseph A Aguilera; Sunil Advani; Laura E Crotty Alexander; Kevin T Brumund; Jessica Wang-Rodriguez; Weg M Ongkeko Journal: Oral Oncol Date: 2015-11-04 Impact factor: 5.337
Authors: D M Burns; E Dybing; N Gray; S Hecht; C Anderson; T Sanner; R O'Connor; M Djordjevic; C Dresler; P Hainaut; M Jarvis; A Opperhuizen; K Straif Journal: Tob Control Date: 2008-04 Impact factor: 7.552
Authors: Alexsandra Ratajczak; Wojciech Feleszko; Danielle M Smith; Maciej Goniewicz Journal: Expert Rev Respir Med Date: 2018-06-08 Impact factor: 3.772
Authors: Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-06-22 Impact factor: 4.254
Authors: Giancarlo A Cuadra; Maxwell T Smith; John M Nelson; Emma K Loh; Dominic L Palazzolo Journal: Int J Environ Res Public Health Date: 2019-05-14 Impact factor: 3.390